Skip to main content
Equibles

BROWN BROTHERS HARRIMAN & CO

Position in GNLX — GENELUX Corp

CIK 14661 NEW YORK, NY
Back to GNLX Full portfolio

Position in GNLX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,063
+$796 QoQ
Shares Held
1,350
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 72 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GNLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BROWN BROTHERS HARRIMAN & CO holds $12,921,641 across 41 Biotechnology names. GNLX ranks #34 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,785 $4,363,773
2 RVMD
Revolution Medicines, Inc.
 15,000 $2,809,200
3 PCVX
Vaxcyte, Inc.
 38,033 $2,210,858
4 INCY
Incyte Corp
 8,005 $907,446
5 REGN
Regeneron Pharmaceuticals, Inc.
 1,115 $695,247
6 MRNA
Moderna, Inc.
 8,626 $604,078
7 TECH
BIO-TECHNE Corp
 4,971 $351,201
8 TTRX
Turn Therapeutics Inc.
 23,688 $172,922

All Filings in GNLX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,063 1,350
2026-03-31 $3,267 1,350
2025-12-31 $5,886 1,350
2025-09-30 $5,670 1,350
2025-06-30 $3,874 1,350
2025-03-31 $39,012 14,449
2024-12-31 $34,099 14,449
2024-09-30 $49,947 21,075
2024-06-30 $23,323 11,961
2024-03-31 $76,922 11,963
2023-12-31 $191,264 13,652
2023-09-30 $334,410 13,655